rs2013738051
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_173493.3(PASD1):c.521G>T(p.Cys174Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 111604Hom.: 0 Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 111604Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33776
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.521G>T (p.C174F) alteration is located in exon 7 (coding exon 6) of the PASD1 gene. This alteration results from a G to T substitution at nucleotide position 521, causing the cysteine (C) at amino acid position 174 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at